A synchronous incidence of breast cancer and follicular lymphoma (FL) is uncommon. The association between these two conditions could be explained by the antigenic stimulation of the adjacent carcinoma and common genetic background. This study aimed to review the literature, and discuss the etiology and management of synchronous breast cancer and FL. Herein, we presented a case of synchronous ductal carcinoma in situ (DCIS) of the breast and FL involving multiple lymph nodes, including those in both axilla. A 49-year-old woman presented with palpable lumps in both axilla. She underwent lumpectomy, radiotherapy, and hormonal therapy for DCIS, while adjuvant chemotherapy was recommended for the lymphoma. Diagnosis was based on histopathologic analysis, such as excision or biopsy.
INTRODUCTION
Breast cancer is the most common malignancy in women, and ductal carcinoma in situ (DCIS) is considered as a precursor of breast cancer [1] . Follicular lymphoma (FL) is the second most common form of non-Hodgkin lymphoma (NHL), which is a lymphoma of follicle center B cells. The frequency of FL in Asian countries is approximately 10% [2] . Previously, cases of breast cancer had been reported after the treatment of hematologic malignancies, such as Hodgkin's disease; however, the synchronous occurrence of breast cancer and lymphoma has been rarely reported [3] . Synchronous presentation of DCIS of the breast and FL is even more rare [4] . Herein, we presented a case where both pathologies coexisted without any history of previous therapy. In addition, a literature review was conducted, and the etiology and management of synchronous breast cancer and FL were discussed.
CASE REPORT
A 49-year-old woman presented with palpable lumps in both axilla a week prior to visiting the hospital. She had significant swelling on both axilla. No family history of breast cancer or lymphoma was reported. Nonspecific induration was palpated on the upper inner quadrant of the right breast. Enlarged lymph nodes were observed in both axilla, which were correlated to swelling. Results of the physical examinations of the left breast, neck, abdomen, and both inguinal area were not significant. Her local therapy was completed along with radiation therapy (RT) of the right breast, and adjuvant hormonal therapy (tamoxifen) was continued. She was scheduled for six cycles of chemotherapy consisting of cyclophosphamide, vincristine, adriamycin, and prednisone.
DISCUSSION
An increased risk of breast cancer has been reported in patients with lymphoma who have been treated with RT [3] . Few articles about secondary lymphoma after adjuvant RT or chemotherapy for breast cancer are also available [5] . However, these two diseases rarely coexist. Two or more primary carcinomas can coexist upon diagnosis or develop consequently, occasionally years after the resection of the first primary tumor. According to the Surveillance, Epidemiology, and
End Results cancer registry, women with a history of breast cancer have a 12% reduced risk of developing NHL [6] .
Several studies on the coexistence of DCIS and FL and its etiology are available. Suresh et al. [7] presented a case of breast cancer that coexisted with B-cell FL and discussed that the antigenic stimulation of the adjacent carcinoma, such as that in breast cancer, may have induced lymphoma genesis. This mechanism is similar to the role of Helicobacter pylori on inflammatory response, which causes stomach mucosa-associated lymphoid tissue (MALT) lymphoma. Stomach MALT lymphoma may be caused by continuous antigenic stimulation from H. pylori infection [8] .
The association between these two diseases could also be explained by a common genetic background or the effects of epidemiologic factors. Ataxia telangiectasia mutated genes, which are observed in lymphoid and breast neoplasms, could be another factor [4] . Wiernik et al. 
92
Eun Young Kim, et al. [9] proposed that the mouse mammary tumor virus (MMTV)-like Env gene can be another cause. These gene sequences were detected in more than one-third of the breast cancer study population, and these sequences were also found in two patients with simultaneous presentation of breast cancer and lymphoma. Moreover, both breast cancer and lymphoma may be caused by an MMTV-like retrovirus.
Finally, even though it was not clear which malignancy-lymphoma or breast cancer-developed first, primary cancer-related immunological impairment predisposes secondary malignancies [10] . Lymphoma may block the flow in the lymphatic vessels and subsequently alter the pathway of metastasis in patients with breast cancer. Furthermore, neoplastic lymphoid cells could decrease interleukin-induced adhesion or the tissue necrosis factor of breast cancer cells to the endothelial layer of the axillary lymph nodes, promoting metastasis to certain lymph nodes [11] .
In summary, the synchronous presentation of DCIS and FL is rare and difficult to diagnose. As in our case, the diagnosis of lymphadenopathy as a lymphoproliferative disease rather than breast metastasis was challenging. Multiple enlarged axillary lymph nodes on both sides that are found during physical examination or imaging studies should be meticulously diagnosed, particularly in patients with no signs of abnormal breast lesions. Such lymphadenopathy could prevent other malignancies or inflammatory disorders rather than metastatic diseases. Histopathologic confirmation of the synchronous presentation of both breast cancer and axillary lesions is indicated. Thus, clinicians must acknowledge that two different malignancies can coexist, and the recognition of the coexistence can help in the development of treatment plans for both diseases in the future.
